UCLA's Heart Transplant Program is one of the world's busiest for adult patients, with more than 2,000 transplants performed since we began in 1984. We have built an international reputation for outstanding success in adult heart transplant.
UCLA Health consistently ranks among the top five hospitals in the nation, and the Best in the West, according to U.S. News & World Report's annual Best Hospitals survey.
This reputation is based in large part on our patient outcomes for heart transplant:
Learn more about our heart transplantation procedure »
While some programs only specialize in one type of care, our team excels in numerous areas of heart transplantation and related medicine:
Care for all phases of cardiovascular dysfunction: Our physicians have expertise in cardiomyopathy, congestive heart failure and congenital heart disease.
Specialization in adult congenital heart disease: The Ahmanson/UCLA Adult Congenital Heart Disease Center offers unique strengths in caring for adult patients with congenital heart disease (CHD). Our heart transplant program works closely with the center, and in the past decade, we've demonstrated that even the highest-risk CHD patients can have excellent transplantation outcomes.
Pediatric-to-adult transition: UCLA provides pediatric heart transplant and then follow-up care through adulthood, in one facility, with one collaborative medical team. Our specially trained transition to adult care coordinators address each patient's individual needs.
Often, patients with serious cardiomyopathy find themselves on the path to heart transplant, a potentially life-saving solution.
At UCLA, we believe the best option is to keep your own heart as long as possible. To support that goal, we do everything we can to help patients maintain their heart with reparative therapies before moving toward transplantation or mechanical support. These cardiac surgery therapies might include:
Once reparative options are exhausted, we'll present all other reasonable options for medical therapy and palliative care, following our approach to care.
Patients with cardiomyopathy have access to a full range of treatments, including:
Many patients who come to UCLA for heart transplants are particularly high-risk and may require additional organ transplants. UCLA is at the forefront of combined organ transplant and has successfully treated these complex patients:
Our groundbreaking heart transplant program has developed and improved the approaches that now define heart transplantation care.
We're also making advances in operational techniques, foundational biology, immunology, genome-based therapy and pharmacological therapy for end-stage heart disease. Learn more about our research and trials.
We offer ongoing support for all heart transplant patients:
Learn more about the patient experience on our patient education page.